Market Overview

Why Zosano Pharma's Stock Is Trading Lower Today


Zosano Pharma (NASDAQ: ZSAN) shares are trading lower on Wednesday after the company announced it received a complete response letter from the FDA for its Qtrypta.

Zosano Pharma is a clinical-stage specialty pharmaceutical company. It has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of various indications.

Zosano Pharma shares traded down 27.14% to 45 cents on Wednesday at the time of publication. The stock has a 52-week high of $2.45 and a 52-week low of 40 cents.


Related Articles (ZSAN)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Penny Stocks FDA

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at